Diabetic nephropathy is the most common cause of end-stage renal disease in the United States [1, 2] Abstract Aim/hypothesis. We aimed to determine variations in the prevalence of increased urinary albumin excretion, associated risk factors and complications in patients with diabetes participating in the WHO Multinational Study of Vascular Disease in Diabetes follow-up. Methods. Urinary albumin to urinary creatinine ratios were measured centrally in 2033 of the 2550 (79.7 %) re-examined patients from eight centres in seven countries and the frequency of microalbuminuria and macroalbuminuria and their associations with risk factors and complications were examined. Results. Macroalbuminuria prevalence (overall 15.6 %) varied tenfold (3±37 %) among centres, was higher in American Indian and Asian centres and not clearly related to type of diabetes. Microalbuminuria (overall 19.7 %) varied less (12±31 %). Increased albumin excretion was related overall to baseline fasting plasma glucose in the pooled group in whom it was measured and to increased arterial pressure, insulin use, coronary heart disease, lower extremity amputation, retinopathy and stroke in most centres. Conclusion/interpretation. Centres varied widely in the prevalence of increased albumin excretion but associations with risk factors and vascular complications were generally similar in most centres and in both major types of diabetes with ethnic and genetic differences probably contributing. [Diabetologia (2001) 
re-examined at follow-up had measurements of urinary albumin and urinary creatinine on samples collected at the examination visit. All measurements were made by the central laboratory in Phoenix, Arizona in the United States by methods described elsewhere [15] .
The urinary albumin to creatinine ratio (UAC) was used to estimate albumin excretion [16, 17] . Increased UAE was defined as a UAC ratio of 30 mg/g or more and was subdivided into microalbuminuria (UAC ratio 31±299 mg/g) and macroalbuminuria (UAC ratio ³ 300 mg/g). ªClinical proteinuriaº was based on local tests using the Albustix method.
Statistical associations of UAE were explored with factors including sex, age, age at diagnosis of diabetes, duration of diabetes, type of diabetes, treatment for diabetes, systolic, diastolic and mean (1/3 systolic + 2/3 diastolic) arterial pressure, hypertension status, body mass index (BMI ± quartiles by centre), and current smoking status. Fasting plasma glucose was measured at baseline in only a subset of the centres; this yielded 1311 patients with follow-up UAE estimations and these were pooled for analysis. . Associations with vascular complications as defined [15] included coronary heart disease, stroke, lower-extremity amputation, and retinopathy.
Standard statistical methods [15] and the natural logarithm of the UAC ratio for Pearson correlation coefficients were used. Stratified analysis used the Mantel and Haenszel statistic [19] . Odds ratios with adjustment for sex, age and duration of diabetes used SAS [18] and BMDP [20] in multivariate stepwise linear logistic regression analyses to identify factors significantly related to increased UAE.
Results
The prevalence of increased UAE at follow-up by centre is shown in Table 1 . Macroalbuminuria rates varied tenfold, being highest in Oklahoma and Arizona and lowest in London and were little affected after stratification by sex and type of diabetes (Fig. 1) . A trend to higher prevalence of increased albumin excretion in Type I (insulin-dependent) than Type II (non-insulin-dependent) diabetes mellitus was not apparent in London or Hong Kong. Of patients with UAC ratios of ³ 300 mg/g or more, 91 % were Albustix positive ( ³ 1 + ) compared with 0.7 % of the patients with UAC ratios of less than 30 mg/g and 19.3 % with UAC ratios of 30 to 299 mg/g.
In the pooled sample of 1311 patients, baseline fasting plasma glucose concentrations significantly correlated with follow-up urinary albumin creatinine ratio (log transformed values r = 0.25 p < 0.0001). This is mainly evident in the positive association of baseline glucose (in tertiles) with follow-up macroalbuminuria (urinary ACR > 299) ( Table 2) .
Within centres, rates of increased UAE differed little with sex (p > 0.05) or age except in Arizona (p < 0.05) but were higher with diabetes diagnosis before the age of 30 in Oklahoma and Berlin (p < 0.05) and for macroalbuminuria in Warsaw and Berlin (p < 0.05). Macroalbuminuria prevalence increased suggestively with duration of diabetes in all centres except London (Fig. 2) . Prevalence of increased UAE was higher in patients receiving insulin than in those on other treatments (p < 0.05) except in Havana and London.
The prevalence of increased UAE was greater in those with higher systolic blood pressure (SBP) at all centres (p < 0.05) and suggestively greater in those with higher diastolic blood pressure (DBP) in six of the eight centres (Fig. 3) . Patients with categorical hypertension had a higher prevalence of increased P. H. Bennett et al.: Urinary albumin excretion and its associations S 38 UAE than those without (p < 0.05), not significant in the American Indian cohorts (Fig. 4) . Current smoking status was positively associated with UAE in Tokyo but negatively in Oklahoma (p < 0.05). BMI was significantly related to UAE only in Warsaw and London (p < 0.05, Fig. 5 ). Mean SBP was higher in patients with increased UAE than in those with normal excretion in all centres (p < 0.05) except Arizona and mean DBP was higher (p < 0.05) in five of the eight. Compared with normoalbuminuric patients, those with increased UAE had higher mean plasma creatinine concentrations at all centres except Warsaw (p < 0.05) and showed significant differences in age, age at diagnosis, duration of diabetes and BMI in one or more centre. Odds ratios (OR) for increased UAE adjusted for age, sex and duration (Table 3) were raised (p < 0.05) for higher SBP at all centres except Arizona, for higher DBP and for insulin treatment compared with other treatments in two centres each. BMI and cigarette smoking were associated with increased UAE in London and Tokyo respectively (p < 0.05).
After stratification for type of diabetes ( Chi-Square 59.5 p < 0.001 gestively in Type II diabetes in seven of the eight centres and with DBP in five centres. Smoking was positively associated with increased UAE in Tokyo, negatively in Oklahoma (p < 0.05) and not associated in other centres (Fig. 7) . Correlations between arterial pressure and UAE were present but less apparent in patients with Type I diabetes. Smoking was not significantly associated in any centre. The prevalence of coronary heart disease was higher in patients with increased UAE than in those with normoalbuminuria at all centres (Table 4) , significantly in London, Hong Kong, Oklahoma, and Arizona (p < 0.05). The prevalence of stroke was significant in Berlin, Hong Kong, Oklahoma and Arizona (p < 0.05). Lower-extremity amputation rates were also higher in patients with increased UAE at all centres except London, but significant only in the American Indian centres (p < 0.05). The prevalence of retinopathy was associated with increased UAE in all centres except Hong Kong and Arizona. In stepwise linear logistic regression analyses (Table 5), mean blood pressure was independently associated with increased UAE in all centres (p < 0.05) except London (p < 0.10). Retinopathy was associated at all centres (p < 0.05) except Warsaw, Hong Kong and Arizona and treatment with insulin was related in Berlin, Hong Kong, Tokyo and Oklahoma (p < 0.05). Diabetes duration was significantly associated in Oklahoma and Arizona, and coronary heart disease in London, Hong Kong and Arizona (p < 0.05). An association with current smoking emerged only in Tokyo (p < 0.05) and with BMI only in London and Warsaw (p < 0.05). Type of diabetes, sex and age were not associated in any centre (p > 0.05).
With macroalbuminuria as a dependent variable (Table 6) , as with microalbuminuria, mean blood pressure was associated in all centres except Oklahoma. Presence of retinopathy was associated with macroalbuminuria in four centres as was insulin use. In Warsaw and Havana, patients with Type I diabetes had a higher prevalence of macroalbuminuria than those with Type II diabetes. An association with smoking was significant only in Tokyo.
When patients were classified into three broad ethnic groups for multivariate analysis, the American Indian group (Oklahoma and Arizona) had a significantly higher prevalence of increased UAE than either the European or the Havana group (OR = 8.7, 95 % CI = 6.3±12.1), or the Asian group (Japan and Tokyo OR = 3.4, 95 % CI = 2.3±5.2) with the Asian group also exceeding the European and Havana group (OR = 3.0, 95 % CI = 2.2±4.0). 
Discussion
Wide variation in the prevalence of increased UAE was observed among the eight centres. In American Indian patients it was more than twice the rate in Asian patients which, in turn, exceeded that in the European and Havana centres. Similar patterns were found in baseline proteinuria using precipitation methods [21, 22] and they are consistent with other reports of higher rates of diabetic nephropathy in Asians and American Indians [23, 24] . These differences were independent of the other risk factors included in the multivariate analyses so that variation in ethnic and/or genetic susceptibility to renal disease [25] could be contributing factors as could varying liability to non-diabetic causes of proteinuria. Our prevalence rates were estimated at follow-up after relatively long diabetes durations (15±23 years) and with varying survivorship among the eight centres [26] . Differences are not likely to have been produced by survival biases; in Arizona, Hong Kong, Tokyo, and Oklahoma higher renal disease mortality during the follow-up period has been reported [26] .
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In this study, UAE was clearly associated with the single baseline measurement of fasting glucose in the pooled subgroup in which the data were available. The relation with higher arterial pressures, observed at all centres, is well recognised [4, 13, 22±24, 27±30]. In Pima Indians, high blood pressure even before diabetes diagnosis predicts increased UAE during its course [31] . The development and progression of clinical nephropathy are accelerated by raised blood pressure. Their correction reduces UAE and delays progression to renal failure [10, 13, 32, 33] . The relation with blood pressure is complex, however, because genetic markers of hypertension could also indicate susceptibility to the development of diabetic nephropathy [34] . The association of UAE with insulin use in Oklahoma, Hong Kong, and Tokyo, as reported by others [29, 35] , probably reflects the effect of the severity of diabetes in terms of the degree of hyperglycaemia.
The association of abnormal UAE with higher prevalence of coronary heart disease, stroke and lower-extremity amputation is consistent with other reports [4, 5, 27, 36] . The expected associations between increased UAE and diabetic retinopathy was present in all centres and consistent with previous observations [4, 22, 26] .
Much of the wide variation in the prevalence of abnormal UAE among the eight centres of this study has yet to be explained. An important contribution of glycaemic control was indicated by the predictive power of the single baseline fasting plasma glucose for incident macroalbuminuria at follow-up. This analysis was limited to a pooled group; therefore we cannot determine if poor glycaemic control had greater impact in one centre than another. The association of abnormal UAE with vascular disease was apparent in all centres, even in those like Tokyo and Arizona with relatively low risk of coronary heart disease and high prevalence of abnormal UAE. The associations of UAE with other risk factors were generally similar. Our findings are consistent with the contention that regional biological or genetic variation could also contribute to the susceptibility to nephropathy. 
